Adenomyosis Clinical Trial
Official title:
Role of Uterine Artery Angioembolization in Management of Uterine Adenomyosis.
Management of symptomatizing women diagnosed with uterine adenomyosis, by uterine artery angioembolization as a minimally invasive replacement for hysterectomy. This is followed by assessment of the symptoms and MRI of the pelvis after 3 months.
Adenomyosis is defined by the abnormal location of endometrial tissue within the myometrium associated with hypertrophy or hyperplasia of the myometrial stroma. Although pathogenesis and etiology of adenomyosis remain unknown, two main theories have been proposed: invagination of the endometrial basal layer and metaplasia of embryonic stem cells. Despite the absence of specific (pathognomonic) diagnostic features for uterine adenomyosis, typical symptoms include menorrhagia, chronic pelvic pain, and dysmenorrhea. For more than a century, diagnosis was dependent on histopathologic examination of post-hysterectomy specimens till the introduction of noninvasive ultrasound and MR techniques. Since then, several studies have illustrated high sensitivities and specificities for both two-dimensional transvaginal sonography (TVS) and magnetic resonance imaging (MRI). Current treatment options for symptomatic adenomyosis include hysterectomy, medication, conservative surgery, or minimally invasive techniques including uterine artery embolization. To date, hysterectomy remains the definitive treatment. This is mainly due to difficult diagnosis, the diffuse nature of the disease, and little evidence-based literature needed to standardize treatments. This consequently results in a management dilemma, particularly in symptomatic patients who wish to preserve their uterus. Uterine artery embolization is the use of transarterial catheters aiming to induce more than 34% necrosis within adenomyotic tissues. Vascular access is gained through a femoral or radial artery puncture using 4-6-French (F) arterial sheath for femoral and 4-F sheath for radial access. Under fluoroscopic guidance, aortography is followed by selective and super selective arteriography using 4-5-F catheters for the internal iliac and 2-3-F microcatheters for the uterine artery and its branches respectively. Embolization is usually performed using variable-sized permanent particulate agents. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04665414 -
Diagnosis of Adenomyosis Using Ultrasound, Elastography and MRI
|
||
Recruiting |
NCT04209127 -
Comparing Efficacy of Microwave vs Embolization Treatment for Adenomyosis
|
N/A | |
Completed |
NCT05751876 -
Dienogest in Perimenopausal Women With Adenomyosis
|
||
Recruiting |
NCT01048931 -
Single-port Access Laparoscopic-assisted Vaginal Hysterectomy
|
Phase 3 | |
Active, not recruiting |
NCT06223464 -
Evaluation of the Relationship Between Adenomyosis and Elastographic Properties of the Cervix
|
||
Completed |
NCT05419414 -
The Use of Shear Wave Elastography, Transvaginal Ultrasound and Pelvic MRI in the Diagnosis of Adenomyosis
|
N/A | |
Recruiting |
NCT05152667 -
Ambispective Study to Assess the Effect of Pretreatment With a Levonorgestrel-Releasing Intrauterine System Versus Oral Progestin
|
||
Not yet recruiting |
NCT03654144 -
Role of Dienogest in the Treatment of Patient With Symptomatic Adenomyosis
|
Phase 4 | |
Completed |
NCT02192606 -
Does 3D Laparoscopy Improve Vaginal Cuff Suture Time?
|
N/A | |
Completed |
NCT01992718 -
What Are we Missing? Diagnosing Uterine Adenomyosis Using Ultrasound Elastography
|
Early Phase 1 | |
Recruiting |
NCT02495311 -
The Association Between Adenomyosis/Uterine Myoma and Lower Urinary Tract Symptoms
|
||
Recruiting |
NCT03742843 -
A Multi-omics Study of Adenomyosis
|
||
Recruiting |
NCT04481321 -
Clinical and Molecular Study of Endometriosis and Adenomyosis
|
||
Recruiting |
NCT04894292 -
The Effect of Adenomoyosis on Pregnancy Outcomes
|
||
Completed |
NCT03520439 -
Evaluation of Therapeutic Effect and Safety of Mifepristone in the Treatment of Adenomyosis
|
Phase 2/Phase 3 | |
Recruiting |
NCT05937490 -
Adenomyosis and ART
|
Phase 4 | |
Recruiting |
NCT06373822 -
New Perspectives in Adenomyosis Pathogenesis With Epigenetic Analysis and miRNAs
|
||
Completed |
NCT01821001 -
Vaginal Bromocriptine for Treatment of Adenomyosis
|
Phase 1 | |
Recruiting |
NCT04295109 -
Comparison of the Effects of Fentanyl, Oxycodone, Butorphanol on Gastrointestinal Function
|
N/A | |
Recruiting |
NCT04356664 -
Benefit of GnRH Agonist Before Frozen Embryo Transfer in Patients With Endometriosis and/or Adenomyosis
|
Phase 2/Phase 3 |